This event will include talks and a networking lunch, followed by opportunities to arrange a 1:1 meeting with representatives from the Medicines Discovery Catapult (MDC). The MDC enables academics and SMEs involved in translational biomedical research to develop their therapeutic discovery projects and associated technologies. Their capabilities include:
- Discovery Science and Technology- Laboratory technology and expertise focused around complex cell models, target validation, biomarkers, drug delivery and pre-clinical imaging.
- Informatics- In silico methods and expertise in screening, repurposing and chemical space searching, including AI and machine learning tools.
- Virtual R&D- Industrially rigorous advice in drug discovery and the delivery of projects.
- Syndicates- New collaborative models for drug discovery centred around medical research charities and patient needs.
- Samples and Data- Brokering access to patient-consented tissue and data.
MDC works with academics and SMEs in a variety of ways, including collaborating on and supporting grant applications.
Agenda
10:15am – 10:30am - Registration
10:30am – 11:00am – An Overview of the Medicines Discovery Catapult (including Q&A) with Graeme Wilkinson
11:00am – 11:30am - Delivering Informatics Approaches to Drive Smart Decision Making in Drug Discovery (including Q&A) with Mark Davies
11:30am – 12:00pm – Cutting-edge Discovery Science & Technology (including Q&A) with Martin Main
12:00pm- 1:00pm - Lunch
1:00pm- 4:00pm - 1:1 sessions – come and ask the questions you have about drug discovery
